EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

Efficacy and compliance of carbohydrate-restricted diets for treating drug-resistant epilepsy: A network meta-analysis of randomized controlled trials

Kun Zhu, Qilin Peng, Danfeng Cao, Bo Xiao, Honghao Zhou, Boting Zhou, Xiaoyuan Mao, Zhaoqian Liu

Epilepsy & Behavior · 2025

DOI: 10.1016/j.yebeh.2025.110434 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Kun Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China. Electronic address: zhukun@c…. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Randomized Controlled Trials as Topic, Diet, Carbohydrate-Restricted, Patient Compliance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China, Key Research and Development Program of Hunan Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Drug-resistant epilepsy (DRE) presents a significant clinical challenge since many patients fail to respond adequately to pharmacological treatments, resulting in persistent seizures and a great decline in quality of life. This highlights the urgent need for alternative or adjunctive therapeutic strategies. Carbohydrate-restricted diets have emerged as promising adjunctive treatments for epilepsy. However, while the efficacy of these diets has been well-established in pediatric populations, their effectiveness on adult DRE patients remains underexplored. This study aims to evaluate and compare the efficacy of various carbohydrate-restricted diets in treating DRE among all age groups, providing valuable insights into their potential clinical applications. METHODS: PRISMA guidelines for network meta-analysis were followed. Randomized controlled trials (RCTs) comparing the efficacy of different carbohydrate-restricted diets in DRE patients, and published in PubMed, Embase, Cochrane, and Web of Science up to 22 December 2023 were screened. The primary outcomes were >50 %, >90 % seizure frequency reduction from the baseline and seizure freedom. Secondary outcomes included compliance and adverse events. Random-effects models with a Bayesian-based approach were employed to estimate between-group comparisons, with results presented as odds ratios (OR) and 95 % credible intervals (CrI). RESULTS: A total of 17 RCTs involving 1468 DRE patients were included. The diets evaluated were the ketogenic diet (KD), modified Atkins diet (MAD), and low glycemic index treatment (LGIT). For >50 % and >90 % seizure reduction from baseline, all three diets resulted in significant efficacy compared to the normal diet. Notably, MAD was the only diet that demonstrated a statistically significant association with seizure freedom (OR 7.36, 95 % CrI 2.21-60.36), compared to the normal diet, while its lower compliance (OR 0.39, 95 % CrI 0.18-0.76) was likely influenced by the inclusion of adult subjects. Adverse effects were reported across all three diets with similar profiles, highlighting the need for individualized monitoring. CONCLUSIONS: This meta-analysis indicated that in RCTs, the included diet therapies were overall equivalent in efficacy and side effects, with the MAD showing a higher chance of seizure freedom. Compliance was lower with the MAD, but this was likely due to a preponderance of adult studies using this therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyRandomized Controlled Trials as TopicDiet, Carbohydrate-RestrictedPatient ComplianceHumansTreatment OutcomeDiet, Ketogenic

Stichwörter der Autor:innen

ComplianceEpilepsyKetogenic dietLow glycemic index treatmentSeizure controlmodified Atkins diet

Autor:innen und Institutionen

  • Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China. Electronic address: zhukun@csu.edu.cn.
  • Department of Pharmacy, Xiangya Hospital Central South University, Changsha 410008, China. Electronic address: qilinpeng@csu.edu.cn.
  • Academician Workstation and Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, Changsha Medical University, Changsha 410219, China. Electronic address: caodf2…
  • Department of Neurology, Xiangya Hospital Central South University, Changsha 410008, China. Electronic address: xiaobo_xy@126.com.
  • Department of Clinical Pharmacology and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University, Changsha 410008, China; Institute of Clinical Pharmacology and Engineering Re…
  • Department of Pharmacy, Xiangya Hospital Central South University, Changsha 410008, China. Electronic address: botingzhou0918@126.com.

Förderung

  • Natural Science Foundation of Hunan Province
  • National Natural Science Foundation of China
  • Key Research and Development Program of Hunan Province of China

Zitieren

APA

Zhu, K., Peng, Q., Cao, D., Xiao, B., Zhou, H., Zhou, B., Mao, X., & Liu, Z. (2025). Efficacy and compliance of carbohydrate-restricted diets for treating drug-resistant epilepsy: A network meta-analysis of randomized controlled trials. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110434

Vancouver

Zhu K, Peng Q, Cao D, Xiao B, Zhou H, Zhou B, et al. Efficacy and compliance of carbohydrate-restricted diets for treating drug-resistant epilepsy: A network meta-analysis of randomized controlled trials. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2025.110434

BibTeX
@article{Zhu2025,
  author = {Zhu, Kun and Peng, Qilin and Cao, Danfeng and Xiao, Bo and Zhou, Honghao and Zhou, Boting and Mao, Xiaoyuan and Liu, Zhaoqian},
  title = {Efficacy and compliance of carbohydrate-restricted diets for treating drug-resistant epilepsy: A network meta-analysis of randomized controlled trials},
  journal = {Epilepsy & Behavior},
  year = {2025},
  doi = {10.1016/j.yebeh.2025.110434}
}
Kostenlos starten →